Wall Street Trader schreef op 14 augustus 2020 19:59:
[...]Only one more week to go, then it's showtime!2020 newsflow• Filgotinib
US approval/label information• NOVESA
ziritaxestat Ph2a SSc (data we can expect shortly)• PINTA
‘1205 Ph2a IPF (Q4)• ROCCELLA
‘1972 Ph2b OA (Q4) (Walid Abi-Saab; We're still on track to have the data in the second half of the year for the study).• TOLEDO
launch of `3970 exploratory Phase II trials with anticipated readout 1H21
We expect a significant proportion of the c.$5bn from Gilead to be used to accelerate GLPG's secretive Toledo programme in order to maximise first-mover advantage with this undisclosed mechanism of action.
Onno van de Stolpe;
If Toledo is successful (and we’re all convinced that it will be), it will work even better than current drugs like the JAK inhibitors or the TNFs. This is the biggest pharma market in the world, and we might have a new mechanism that turns everything upside down.
Galapagos is going full throttle in the upcoming months.www.glpg.com/eventsOnno and IR really needs to bring back the spark in the stock!!
Onno and the rest of the team we are counting on you!